Multiply Labs raised $75 million to expand robotic manufacturing systems designed to integrate between existing cell therapy production instruments. The company said its approach targets labor-heavy logistics steps—such as moving bags, sampling, and transfers—and is focused on linking task-level automation into end-to-end protocols at commercial scale.